227 related articles for article (PubMed ID: 8194612)
1. Benefits of continuous physiological pulsatile gonadotropin-releasing hormone therapy in women with polycystic ovarian syndrome.
Corenthal L; Von Hagen S; Larkins D; Ibrahim J; Santoro N
Fertil Steril; 1994 Jun; 61(6):1027-33. PubMed ID: 8194612
[TBL] [Abstract][Full Text] [Related]
2. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled study comparing the endocrine effects of pulsatile intravenous gonadotropin-releasing hormone after gonadotropin-releasing hormone agonist pretreatment versus clomiphene citrate in patients with polycystic ovary syndrome.
Timmerman-van Kessel EC; Cikot RJ; Dargel-Donkers EJ; Zwertbroek W; van Dop PA; Schoot DC
Fertil Steril; 2000 Jun; 73(6):1145-8. PubMed ID: 10856472
[TBL] [Abstract][Full Text] [Related]
4. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
[TBL] [Abstract][Full Text] [Related]
6. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A
J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
[TBL] [Abstract][Full Text] [Related]
8. Intravenous administration of pulsatile gonadotropin-releasing hormone in hypothalamic amenorrhea: effects of dosage.
Santoro N; Wierman ME; Filicori M; Waldstreicher J; Crowley WF
J Clin Endocrinol Metab; 1986 Jan; 62(1):109-16. PubMed ID: 3079597
[TBL] [Abstract][Full Text] [Related]
9. The treatment of luteal phase defects with pulsatile infusion of gonadotropin-releasing hormone.
Loucopoulos A; Ferin M
Fertil Steril; 1987 Dec; 48(6):933-6. PubMed ID: 3119374
[TBL] [Abstract][Full Text] [Related]
10. [Ovulation induction with pulsatile gonadotropin-releasing hormone and continuous human menopausal gonadotropin in polycystic ovarian disease].
Kuroda G
Nihon Naibunpi Gakkai Zasshi; 1987 Mar; 63(3):247-59. PubMed ID: 3111899
[TBL] [Abstract][Full Text] [Related]
11. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
Pastor CL; Griffin-Korf ML; Aloi JA; Evans WS; Marshall JC
J Clin Endocrinol Metab; 1998 Feb; 83(2):582-90. PubMed ID: 9467578
[TBL] [Abstract][Full Text] [Related]
12. Value of subcutaneous and intravenous pulsatile gonadotropin releasing hormone in polycystic ovary disease.
Saffan DS; Seibel MM
J Reprod Med; 1992 Jun; 37(6):545-51. PubMed ID: 1619610
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a specific role of GnRH pulse frequency in the control of the human menstrual cycle.
Filicori M; Flamigni C; Campaniello E; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A; Valdiserri A
Am J Physiol; 1989 Dec; 257(6 Pt 1):E930-6. PubMed ID: 2514600
[TBL] [Abstract][Full Text] [Related]
14. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome.
Kettel LM; Roseff SJ; Berga SL; Mortola JF; Yen SS
Fertil Steril; 1993 Mar; 59(3):532-8. PubMed ID: 8458453
[TBL] [Abstract][Full Text] [Related]
17. Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH.
Tan SL; Farhi J; Homburg R; Jacobs HS
Obstet Gynecol; 1996 Aug; 88(2):221-6. PubMed ID: 8692506
[TBL] [Abstract][Full Text] [Related]
18. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
Couzinet B; Young J; Brailly S; Chanson P; Schaison G
J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
[TBL] [Abstract][Full Text] [Related]
19. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone in various ovulatory disorders.
Saffan D; Seibel MM
Fertil Steril; 1986 Apr; 45(4):475-82. PubMed ID: 3082681
[TBL] [Abstract][Full Text] [Related]
20. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea.
Martin KA; Hall JE; Adams JM; Crowley WF
J Clin Endocrinol Metab; 1993 Jul; 77(1):125-9. PubMed ID: 8325934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]